Formoterol PLGA-PEG Nanoparticles Induce Mitochondrial Biogenesis in Renal Proximal Tubules.

Adrenergic beta-2 Receptor Agonists / administration & dosage Animals Cells, Cultured Drug Liberation Female Formoterol Fumarate / administration & dosage Humans Kidney Tubules, Proximal / cytology Male Mice Mitochondria / drug effects Models, Animal Nanoparticle Drug Delivery System / chemistry Organelle Biogenesis Polyethylene Glycols / chemistry Polylactic Acid-Polyglycolic Acid Copolymer / chemistry Primary Cell Culture Rabbits Renal Insufficiency / drug therapy
controlled drug release formoterol mitochondrial biogenesis nanoparticles kidney primary cell culture

Journal

The AAPS journal
ISSN: 1550-7416
Titre abrégé: AAPS J
Pays: United States
ID NLM: 101223209

Informations de publication

Date de publication:
24 06 2021
Historique:
received: 10 03 2021
accepted: 04 06 2021
entrez: 25 6 2021
pubmed: 26 6 2021
medline: 11 1 2022
Statut: epublish

Résumé

Formoterol is a long-acting β

Identifiants

DOI: 10.1208/s12248-021-00619-4 PMID: 34169439 PMC: PMC8734428
pubmed: 34169439
doi: 10.1208/s12248-021-00619-4
pii: 10.1208/s12248-021-00619-4
pmc: PMC8734428
mid: NIHMS1756625
doi:

Substances chimiques

Adrenergic beta-2 Receptor Agonists 0
Nanoparticle Drug Delivery System 0
Polylactic Acid-Polyglycolic Acid Copolymer 1SIA8062RS
Polyethylene Glycols 3WJQ0SDW1A
Formoterol Fumarate W34SHF8J2K

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

88

Subventions

Organisme : NCI NIH HHS
ID : P30 CA023074
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES006694
Pays : United States
Organisme : NIH HHS
ID : S10 OD011981
Pays : United States

Références

Nano Lett. 2015 Apr 8;15(4):2358-64
pubmed: 25811353
Am J Physiol Renal Physiol. 2020 Feb 1;318(2):F322-F328
pubmed: 31841384
Exp Mol Pathol. 2009 Jun;86(3):215-23
pubmed: 19186176
Pharmaceutics. 2020 Dec 25;13(1):
pubmed: 33375607
Xenobiotica. 1982 Dec;12(12):803-12
pubmed: 7170790
Am J Kidney Dis. 2009 Jun;53(6):961-73
pubmed: 19346042
Kidney Int. 2020 Jul;98(1):76-87
pubmed: 32386967
Int J Pharm. 2012 Apr 15;426(1-2):193-201
pubmed: 22274587
Int J Pharm. 2013 Oct 15;455(1-2):374-92
pubmed: 23820131
Circulation. 1989 Jan;79(1):107-15
pubmed: 2562936
Biochem Biophys Res Commun. 2007 Apr 13;355(3):734-9
pubmed: 17307137
J Biol Chem. 2007 Jan 26;282(4):2355-62
pubmed: 17116659
Biomaterials. 2019 Oct;219:119368
pubmed: 31349200
Pharmaceutics. 2014 Jun 20;6(2):333-53
pubmed: 24955820
Hypertension. 2018 Jan;71(1):87-94
pubmed: 29133360
J Pharmacol Exp Ther. 2019 May;369(2):188-199
pubmed: 30819762
J Pharmacol Exp Ther. 2012 Jul;342(1):106-18
pubmed: 22490378
J Pharmacol Exp Ther. 2010 May;333(2):593-601
pubmed: 20103585
Br J Pharmacol. 2006 Mar;147(6):583-6
pubmed: 16432500
Eur J Pharmacol. 2002 Dec 5;456(1-3):69-75
pubmed: 12450571
Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):E211-7
pubmed: 21628559
Kidney Int. 2001 Feb;59(2):515-31
pubmed: 11168934
J Pharmacol Exp Ther. 2019 Apr;369(1):173-180
pubmed: 30709866
Biomaterials. 2009 May;30(14):2790-8
pubmed: 19232712
Mol Pharm. 2011 Dec 5;8(6):2101-41
pubmed: 21974749
Polymers (Basel). 2011 Sep 1;3(3):1377-1397
pubmed: 22577513
Eur J Pharmacol. 2017 Oct 15;813:105-121
pubmed: 28754379
N Engl J Med. 2013 Dec 26;369(26):2492-503
pubmed: 24206459
J Control Release. 2007 May 14;119(1):41-51
pubmed: 17346845
Int J Pharm. 2020 Jun 30;584:119455
pubmed: 32464235
Am J Physiol Renal Physiol. 2005 Jun;288(6):F1092-102
pubmed: 15625081
Annu Rev Med. 2012;63:185-98
pubmed: 21888516
Am J Physiol. 1995 Apr;268(4 Pt 1):C1053-61
pubmed: 7733227
Kidney Int. 2009 Oct;76(8):813-4
pubmed: 19789540
J Pharm Sci. 1998 Oct;87(10):1229-34
pubmed: 9758682
Biochem Pharmacol. 2019 Nov;169:113644
pubmed: 31542386
Sci Rep. 2017 Sep 5;7(1):10578
pubmed: 28874749
Physiol Rev. 2008 Apr;88(2):611-38
pubmed: 18391175
J Am Soc Nephrol. 2014 Jun;25(6):1157-62
pubmed: 24511124
Kidney Int. 2019 Sep;96(3):656-673
pubmed: 31262488
Kidney Int. 2016 Oct;90(4):740-5
pubmed: 27292222
Am J Physiol Renal Physiol. 2020 Nov 1;319(5):F773-F779
pubmed: 32954853
Int J Mol Sci. 2010 Sep 15;11(9):3298-322
pubmed: 20957095
Mater Sci Eng C Mater Biol Appl. 2021 Jan;118:111427
pubmed: 33255024
Nat Rev Nephrol. 2017 Oct;13(10):629-646
pubmed: 28804120
Pharmacol Rev. 1991 Jun;43(2):203-42
pubmed: 1677200
PLoS One. 2016 Apr 01;11(4):e0152005
pubmed: 27035432
Nephrology (Carlton). 2019 May;24(5):497-503
pubmed: 30848004
Prog Pediatr Cardiol. 2011 Jan 1;31(1):35-38
pubmed: 21765627
AAPS J. 2020 Nov 16;23(1):2
pubmed: 33200330
ACS Nano. 2015;9(4):3641-53
pubmed: 25790730
Biomaterials. 2006 Jul;27(21):4025-33
pubmed: 16564085
Ann N Y Acad Sci. 2005 Jun;1047:248-58
pubmed: 16093501
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2826-31
pubmed: 10717001
Lancet. 2012 Aug 25;380(9843):756-66
pubmed: 22617274
Adv Chronic Kidney Dis. 2013 Nov;20(6):500-7
pubmed: 24206602
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jan 2;830(1):25-34
pubmed: 16275132

Auteurs

Ernest L Vallorz (EL)

Department of Pharmacology and Toxicology, The University of Arizona College of Pharmacy, Tucson, Arizona, 85721, USA.

Karen Blohm-Mangone (K)

Department of Pharmacology and Toxicology, The University of Arizona College of Pharmacy, Tucson, Arizona, 85721, USA.

Rick G Schnellmann (RG)

Department of Pharmacology and Toxicology, The University of Arizona College of Pharmacy, Tucson, Arizona, 85721, USA.
Department of Medicine, The University of Arizona College of Medicine, Tucson, Arizona, 85724, USA.
BIO5 Institute, The University of Arizona, Tucson, Arizona, 85719, USA.
Southern Arizona VA Health Care System, Tucson, Arizona, 85723, USA.

Heidi M Mansour (HM)

Department of Pharmacology and Toxicology, The University of Arizona College of Pharmacy, Tucson, Arizona, 85721, USA. mansour@pharmacy.arizona.edu.
Department of Medicine, The University of Arizona College of Medicine, Tucson, Arizona, 85724, USA. mansour@pharmacy.arizona.edu.
BIO5 Institute, The University of Arizona, Tucson, Arizona, 85719, USA. mansour@pharmacy.arizona.edu.
Colleges of Pharmacy & Medicine, The University of Arizona, 1703 E. Mabel St, Tucson, Arizona, 85721-0207, USA. mansour@pharmacy.arizona.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents neuromédiateurs › Agents adrénergiques › Agonistes adrénergiques › Agonistes bêta-adrénergiques › Agonistes des récepteurs béta-2 adrénergiques › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Eucaryotes › Animaux › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Cellules › Cellules cultivées › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Pharmacocinétique › Libération de médicament › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Composés chimiques organiques › Amines › Aminoalcools › Éthanolamines › Fumarate de formotérol › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Appareil urogénital › Voies urinaires › Rein › Néphrons › Tubules rénaux › Tubules contournés proximaux › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Cellules › Structures cellulaires › Fractions subcellulaires › Mitochondries › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Techniques d'investigation › Modèles animaux › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Systèmes de délivrance de médicaments › Vecteurs de médicaments › Système d'administration de médicaments à base de nanoparticules › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Phénomènes biologiques › Biogenèse des organelles › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Technologie, industrie et agriculture › Produits manufacturés › Matériaux biomédicaux et dentaires › Polymères › Polyéthylène glycols › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Technologie, industrie et agriculture › Produits manufacturés › Matériaux biomédicaux et dentaires › Polymères › Polyesters › Acide polyglycolique › Copolymère d'acide poly(lactique-co-glycolique) › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Techniques d'investigation › Techniques in vitro › Techniques de culture › Techniques de culture cellulaire › Culture de cellules primaires › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Lagomorpha › Lapins › Formoterol PLGA-PEG Nanoparticles Induce...
questionsmedicales.fr › Maladies urogénitales › Maladies urologiques › Maladies du rein › Insuffisance rénale › Formoterol PLGA-PEG Nanoparticles Induce...